AMGEVITA adalimumab (rch) 20mg/0.4mL injection solution syringe

Amgen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1d5cb6991fdf5281
Product Name: AMGEVITA adalimumab (rch) 20mg/0.4mL injection solution syringe
Artg Id: 278702
Artg Name: AMGEVITA adalimumab (rch) 20mg/0.4mL injection solution syringe
Sponsor: Amgen Australia Pty Ltd
Company Detail Path: /organization/amgen-australia-pty-ltd
Artg Date: 2017-11-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01222-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-PI-02666-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

1d5cb6991fdf5281

Type

Standard